Drugs

Resources for You

Current Drug Shortages L - N

The majority of information in this section is provided to FDA by manufacturers. Communication between FDA and the public is an essential component of preventing and mitigating drug shortages. To ensure that the information in this section is current, FDA appreciates all information and updates about shortages provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers. To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov. Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.

*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

**Listed by Generic name or Active Ingredient**

A B C D E F G H I J K [L – N] O P Q R S T U V W X Y Z

Leucovorin Calcium Lyophilized Powder for Injection

** Please note Levoleucovorin (Fusilev) is available in ample quantities**There is potential for dosing errors when interchanging leucovorin and levoleucovorin (Fusilev). The dose of levoleucovorin (Fusilev) is one-half the dose of racemic leucovorin injection (e.g., levoleucovorin [Fusilev] 7.5 mg = racemic leucovorin 15 mg). For more information visit: Spectrum Pharmaceuticals web site.

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Bedford Laboratories Customer Service 1-800-562-4797	50 mg (NDC 55390-0005-10)	Available		Demand increase for the drug.	Revised 4/2/2013
	100 mg (NDC 55390-0052-10)	Available
	200 mg (NDC 55390-0053-01)	Available
	350mg (NDC 55390-0054-01)	Available
	500mg 50mL solution (NDC 55390-0009-01)	The 500 mg / 50 mL solution is currently backordered and release dates are to be determined.
Teva Pharmaceuticals 1-800-545-8800	100mg/vial (NDC 0703-5140-01) 20mL	Teva, in conjunction with the FDA, is initiating a temporary importation of Leucovorin Calcium Folinate Solution for Injection, to the United States market to address the current shortage. Teva has the 30ml presentation available , ndc 00703-2797-01	See Dear Healthcare Professional letter (PDF 692KB) for additional information. Teva has limited inventory available of both presentations.	Regulatory delay.	Reverified 4/29/2013
Teva Pharmaceuticals 1-800-545-8800	350mg/vial (NDC 00703-5145-01) 30mL			Regulatory delay.	Reverified 4/29/2013
APP Pharmaceuticals 1-888-386-1300	200 mg SDV (NDC 63323-710-50)	Available. Check wholesalers for inventory.	Shortage per Manufacturer: Increased demand	Demand increase for the drug.	Revised 4/30/2013
APP Pharmaceuticals 1-888-386-1300	500 mg SDV (NDC 63323-711-00)	Currently back-ordered. Next release anticipated May 2013.	Shortage per Manufacturer: Increased demand	Demand increase for the drug.	Revised 4/30/2013
Sagent Pharmaceuticals 1-866-625-1618	50 mg vial (NDC 25021-813-10)	Available		Available	Reverified 5/13/2013
	100mg vial (NDC 25021-814-30)	Available
	200mg vial (NDC 25021-815-30)	Available
	350mg vial (NDC 25021-816-30)	Available

Leuprolide Acetate Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Teva 1-800-545-8800	1 mg/0.2 ml (NDC 00703-4014-18)	Teva has Leuprolide Injection on backorder. Teva anticipates product availability in Q2 2013.		Requirements related to complying with good manufacturing practices	Reverified 4/29/2013
Sandoz 1-609-627-8500	1 mg/0.2 ml (NDC 00185-7400-85)	Product now available		Other	Reverified 4/16/2013
Caraco 313-871-8400	1 mg/0.2 ml (NDC 41616-0936-40)	On intermittent backorder.	Shortage per Manufacturer: Increase in demand	Demand increase for the drug.

Levothyroxine sodium (Levoxyl) Tablets (Initial posting-3/15/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Pfizer Customer Service 1-800-533-4535	25 mcg 100 ct (NDC 60793-850-01)	Unavailable Estimated Shortage Duration: Until 2014	Currently on backorder. For information on Levoxyl, please visit : http://www.levoxyl.com/	Other	Revised 4/5/2013
	25 mcg 1000 ct (NDC 60793-850-10)
	50 mcg 100 ct (NDC 60793-851-01)
	50 mcg 1000 ct (NDC 60793-851-01)
	75 mcg 100 ct (NDC 60793-852-01)
	75 mcg 1000 ct (NDC 60793-852-10)
	88 mcg 100 ct (NDC 60793-853-01)
	88 mcg 1000 ct (NDC 60793-853-10)
	100 mcg 100 ct (NDC 60793-854-01)
	100 mcg 1000 ct (NDC 60793-854-10)
	112 mcg 100 ct (NDC 60793-855-01)
	112 mcg 1000 ct (NDC 60793-855-10)
	125 mcg 100 ct (NDC 60793-856-01)
	125 mcg 1000 ct (NDC 60793-856-10)
	137 mcg 100 ct (NDC 60793-857-01)
	137 mcg 1000 ct (NDC 60793-857-10)
	150 mcg 100 ct (NDC 60793-858-01)
	150 mcg 1000 ct (NDC 60793-858-10)
	175 mcg 100 ct (NDC 60793-859-01)
	175 mcg 1000 ct (NDC 60793-859-10)
	200 mcg 100 ct (NDC 60793-860-01)
	200 mcg 1000 ct (NDC 60793-860-10)

Lidocaine Hydrochloride (Xylocaine) Injection (Initial Posting Date) - 2/22/2012

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP Customer Service: 1-888-386-1300	Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57)	Available. Check Wholesalers for inventory.	All lidocaine and Xylocaine presentations are on intermittent back order and will be released as the product becomes available. Shortage per Manufacturer: Increase in demand	Demand increase for the drug.	Reverified 4/30/2013



	Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57)	Available. Check Wholesalers for inventory.
	Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02	Available. Check Wholesalers for inventory.
	Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10)	Available. Check Wholesalers for inventory.
	Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27)	Available. Check Wholesalers for inventory.
	Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57)	Available. Check Wholesalers for inventory.
	Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27)	Available. Check Wholesalers for inventory.
	Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80)	Available. Check Wholesalers for inventory.
	Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89)	Backordered. No estimated delivery at this time.
	Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57)	Available. Check Wholesalers for inventory.
	Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37)	Available. Check Wholesalers for inventory.
	Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31)	Available. Check Wholesalers for inventory.
	Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97)	Backordered. No estimated delivery at this time.
	Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91)	Backordered. No estimated delivery at this time.
	Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02)	Available. Check Wholesalers for inventory.
	Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05)	Backordered. Next release anticipated June 2013.
	Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17)	Available. Check Wholesalers for inventory.
	Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27)	Available. Check Wholesalers for inventory.
	Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57)	Available. Check Wholesalers for inventory.
	Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10) discontinued
	Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued
	Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50) – NDC discontinued
	Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27)	Available. Check Wholesalers for inventory.
	Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07)	Available. Check Wholesalers for inventory.
	Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97)	Backordered. No Estimated delivery at this time..
Hospira, Inc. Customer Service: 1-877-946-7747	0.5% w/EPI 1:100,000; 1.8 mL Carpule (NDC 0409-0996-01)	Next delivery 1Q 2013 Estimated recovery 2Q 2013	Please check with your wholesaler for available inventory. Shortage of Manufacturer: manufacturing delay/Availlable; Material shortage/Available	Other	Revised 5/3/2013
	0.5% w/EPI 1:200,000; 50 mL vial (NDC 0409-3177-01)	Available
	1% w/EPI 1:100,000; 20 mL vial (NDC 0409-3178-01)	Available
	1% w/EPI 1:100,000; 30 mL vial (NDC 0409-3178-02)	Available
	1% w/EPI 1:100,000; 50 mL vial (NDC 0409-3178-03)	Next delivery May Estimated recovery: 2Q 2013
	1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-01)	Next delivery May Estimated recovery 2Q 2013
	1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-65)	Available
	1.5% w/EPI 1:200,000; 30 mL amp (NDC 0409-3181-01)	Next delivery June Estimated recovery 2Q 2013
	2% w/EPI 1:100,000; 20 mL vial (NDC 0409-3182-01)	Available
	2% w/EPI 1:100,000; 30 mL vial (NDC 0409-3182-02)	Available
	2% w/EPI 1:100,000; 50 mL vial (NDC 0409-3182-03)	Available
	2% w/EPI 1:200,000; 20 mL vial (NDC 0409-3183-01)	Next delivery June Estimated recovery 2Q 2013
	2% w Epi 1:50,000; 1.8mL syringe (NDC 0409-7263-01)	Temporarily suspended
	.0.5%; 50 mL FT vial (NDC 0409-4275-01)	Next delivery May Estimated recovery: 2Q 2013
	0.5%; 50 mL TT vial (NDC 0409-4278-01)	Available
	1%; 5mL Ansyr Syringe (NDC 0409-9137-05)	Next delivery April Estimated recovery 2Q 2013
	5% w/7.5% Dex; 2mL amp (NDC 00409-4712-01)	Next delivery May Estimated recovery 2Q 2013
	1%; 2 mL amp (NDC 0409-4713-32)	Available
	1%; 20 mL vial (NDC 0409-4276-01)	Available
	1%; 30 mL vial (NDC 0409-4279-02)	Available
	1%; 50 mL vial (NDC 0409-4276-02)	Available
	1%; 30 mL Sterile Pack vial (NDC 0409-4270-01)	Available
	2%; 2 mL amp (NDC 0409-4282-01)	Available
	2%; 10 mL amp (NDC 0409-4282-02)	Available
	1%; 5 mL Abboject syringe (NDC 0409-4904-34)	Available
	2%; 5 mL Abboject syringe (NDC 0409-4903-34)	Next delivery April Estimated recovery 2Q 2013
	2%; 5 mL vial (NDC 0409-2066-05)	Available
	2%; 20 mL vial (NDC 0409-4277-01)	Available
	2%; 50 mL vial (NDC 0409-4277-02)	Available
	4%; 5 mL amp (NDC 0409-4283-01)	Available
	Product 1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-65)	Available
	0.4% in 5% Dex; 500mL flex (NDC 00409-7931-24)	Next delivery and estimated recovery 2014
	0.4% I n5% Dex; 250mL flex (NDC 00409-7931-32)	Next delivery and estimated recovery 2014
	0.8% in 5% Dex; 250mL flex (NDC 00409-7939-32)	Next delivery and estimated recovery 2014
	2%; 5mL Ansyr syringe (NDC 0409-1323-05)	Next delivery April Estimated recovery: 2Q 2013.
	2%; 5mL Ansyr syringe (NDC 0409-1323-05)	Next delivery April Estimated recovery: 2Q 2013.
Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136	2%, 5mL Luer-Jet Prefilled Syringe NDC 76329-3390-1 (old NDC 0548-3390-00)	Amphastar will regularly release products.	Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. Shortage per Manufacturer: Increased Demand	Demand increase for the drug.	Reverified 5/13/2013
American Regent/Luitpold 1-800-645-1706	1%, 50 mL vial package of 25 (NDC 00517-0625-25)	Unavailable	American Regent/Luitpold has discontinued manufacturing Lidocaine HCl Injection, USP	Other	Reverified 5/7/2013
American Regent/Luitpold 1-800-645-1706	2%, 50 mL vial package of 25 (NDC 00517-0626-25)	Unavailable		Other	Reverified 5/7/2013

Lidocaine HCl, 4% Topical Solution (Initial Posting 2/12/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136	4mL Laryng-O-Jet NDC 76329-6300-5 (old NDC 0548-6300-00)	Available		N/A	Revised 5/13/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Amphastar Pharmaceuticals, Inc. Customer Service:

1-800-423-4136

4mL Laryng-O-Jet

NDC 76329-6300-5

(old NDC 0548-6300-00)

Available

N/A

Revised 5/13/2013

Liotrix (Thyrolar) Tablets

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Forest Pharmaceuticals 1-800-678-1605		Forest has not yet reported when Thyrolar will be available.	Shortage per Manufacturer: Manufacturing delays	Other

Lomustine Capsules (Initial posting - 5/9/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
NextSource Biotechnology, LLC Customer Service: 1-855-672-2468	Lomustine capsules 10 mg: 5 count/bottle NDC 58181-3030-5 (Old BMS NDC# 0015-3030-20; 20 count/bottle)	Limited supply available for allocation as of 5/16/2013- For emergency direct or drop shipment, contact customer service: 1-855-672-2468. Continued releases anticipated. Estimated recovery: 3Q 2013	Divestiture of ownership for Lomustine capsules from Bristol Myers Squibb Company (BMS) to Corden Pharma Latina S.p.A. The new distributor in US market is NextSource Biotechnology LLC. Corden Pharma Latina S.p.A./NextSource Biotechnology LLC is currently working with FDA to alleviate shortage. See Dear Healthcare Professional Letterr (PDF - 113KB) for additional information	Other	Revised 5/16/2013
Lomustine capsules 40 mg: 5 count/bottle NDC 58181-3031-5 (Old BMS NDC# 0015-3031-20; 20 count/bottle)
Lomustine capsules 100 mg: 5 count/bottle NDC 58181-3032-5 (Old BMS NDC# 0015-3032-20; 20 count/bottle)	Estimated recovery 3Q 2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

NextSource Biotechnology, LLC

Customer Service: 1-855-672-2468

Lomustine capsules 10 mg: 5 count/bottle NDC 58181-3030-5 (Old BMS NDC# 0015-3030-20; 20 count/bottle)

Limited supply available for allocation as of 5/16/2013- For emergency direct or drop shipment, contact customer service: 1-855-672-2468.
Continued releases anticipated. Estimated recovery: 3Q 2013

Divestiture of ownership for Lomustine capsules from Bristol Myers Squibb Company (BMS) to Corden Pharma Latina S.p.A.
The new distributor in US market is NextSource Biotechnology LLC.

Corden Pharma Latina S.p.A./NextSource Biotechnology LLC is currently working with FDA to alleviate shortage.

See Dear Healthcare Professional Letterr (PDF - 113KB) for additional information

Other

Revised 5/16/2013

Lomustine capsules 40 mg: 5 count/bottle NDC 58181-3031-5 (Old BMS NDC# 0015-3031-20; 20 count/bottle)

Lomustine capsules 100 mg: 5 count/bottle NDC 58181-3032-5 (Old BMS NDC# 0015-3032-20; 20 count/bottle)

Estimated recovery 3Q 2013

Lorazepam (Ativan) Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	2 mg/mL, 1 mL vial (NDC 0641-6001-25)	West-Ward currently has limited inventory of Lorazepam Injection, USP. West-Ward has accelerated production on all Ativan/Lorazepam Injection product codes	West-Ward is anticipating having additional lots of inventory available in the March 2013 timeframe. Product will be made available as it is released.	Demand increase for the drug	Revised-2/11/2013
	2 mg/mL, 10 mL vial (NDC 0641-6000-10)	On backorder
	4 mg/mL, 1 mL vial (NDC 0641-6003-25)	On backorder
	4 mg/mL, 10 mL vial, (NDC 0641-6002-10)	On backorder
	2 mg/mL, 1 mL vial (NDC 0641-6044-25)	Available
	2 mg/mL, 10 mL vial, (NDC 0641-6046-10)	Available
	4 mg/mL, 1 mL vial (NDC 0641-6045-25)	Available
	4 mg/mL, 10 mL vial, (NDC 0641-6047-10)	Available
Bedford Laboratories Customer Service: 1-800-562-4797	2 mg/mL, 1 mL vial (NDC 55390-0168-10), 10 mL vial (NDC 55390-0170-10)	Product Discontinued: Bedford currently has all presentations discontinued.	Shortage per Manufacturer: Not currently marketed.	Discontinuation of the manufacture of the drug.
Hospira Inc. Customer Service: 1-877-946-7747	2 mg/mL; 1 mL vial (NDC 00409-6778-02)	Next delivery mid May Estimated recovery 2Q 2013	Please check with your wholesaler for available inventory. Shortage per Manufacturer: Manufacturing delay/Available	Other Demand increase for the drug.	Revised 5/3/2013
	2 mg/mL; 10 mL vial (NDC 0409-6780-02)	Available
	2 mg/mL; 1 mL Carpuject syringe (NDC 0409-1985-30)	Available
	2 mg/mL; 1 mL iSecure syringe (NDC 0409-1985-05)	Discontinued
	4 mg/mL; 1 mL vial (NDC 0409-6779-02)	Available
	4 mg/mL; 10 mL vial (NDC 0409-6781-02)	Next delivery early June Estimated recovery: 2Q 2013
	4 mg/mL; 1 mL Carpuject syringe (NDC 0409-1539-31)	Temporarily unavailable
Akorn Pharmaceutical: 1-800-932-5676	2 mg/mL, 1 mL vial (NDC 17478-0040-01)	Available	NA	NA	Reverified 3/26/2012
Amphastar Pharmaceuticals, Inc./IMS Customer Service: 1-800-423-4136	2mg/mL, 10 mL Vial (NDC 76329-8261-1)	Available		N/A	Reverified 5/13/2013

Magnesium Sulfate Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP: 1-888-386-1300	500 mg/mL, 2 mL vial (NDC 63323-0064-02)	Currently back-ordered. Next delivery expected May 2013. Check wholesalers for inventory.	Check wholesalers for inventory. All other presentations are on intermittent back-order and the company is releasing product as it becomes available. Shortage per Manufacturer: Increased demand for the product.	Demand increase for the drug.	Revised 4/30/2013
	500 mg/mL, 10 mL vial (NDC 63323-0064-10)	Currently back-ordered. Next release anticipated May 2013. Check wholesalers for inventory.
	500 mg/mL, 20 mL vial (NDC 63323-0064-20)	Currently back-ordered. Next delivery expected May 2013.
	500 mg/mL, 50 mL vial (NDC 63323-0064-50)	Currently back-ordered. Next delivery expected May 2013. Check wholesalers for inventory.
American Regent/Luitpold 1-800-645-1706	500 mg/mL, 2 mL vial (NDC 00517-2602-25)	Unavailable	Shortage per Manufacturer: American Regent is currently not releasing Magnesium Sulfate Injection.	Other	Reverified 5/7/2013
	500 mg/mL, 10 mL vial (NDC 00517-2610-25)
	500 mg/mL, 50 mL vial (NDC 00517-2650-25)
Hospira, Inc. Customer Service 1-877-946-7747	50%; 20 mL vial (NDC 0409-2168-02)	Next delivery and estimated recovery TBD	Please check with your wholesaler for available inventory. Shortages per Manufacturer: manufacturing delay	Other	Revised 5/13/2013
	50 %; 10 mL Ansyr syringe (NDC 0409-1754-10)	Next delivery and estimated recovery TBD
	40 mg/mL-water; 50 mL bag (NDC 0409-6729-24)	Next delivery and estimated recovery TBD
	40 mg/mL-water; 100 mL bag (NDC 0409-6729-23)	Next delivery and estimated recovery TBD
	40 mg/mL-water; 500 mL bag (NDC 0409-6729-03)	Next delivery and estimated recovery TBD
	40 mg/mL-water; 1000 mL bag (NDC 0409-6729-09)	Available
	10 mg/mL-dextrose; 100 mL bag (NDC 0409-6727-23)	Next delivery and estimated recovery TBD
	80 mg/mL-water; 50 mL bag (NDC 0409-6730-13)	Next delivery and estimated recovery TBD

Mannitol Injection (Osmitrol, Resectisol) (Initial Posting Date) - 12/21/2011

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP Customer Service: 1-888-386-1300	250 mg/mL, 50 mL vial, 25 count (NDC 63323-0024-25)	Backordered. Check wholesalers for Inventory. Next delivery anticipated late May 2013.	APP has increased production and will have intermittent releases of product. Shortage per Manufacturer: Increase demand	Demand increase for the drug.	Reverified 4/30/2013
B. Braun Medical Inc. Customer Service: 1-800-227-2862	20% Mannitol Injection USP 500 mL flexible plastic container NDC 0264-7578-10	All presentations available.			Revised 10/17/2012
B. Braun Medical Inc. Customer Service: 1-800-227-2862	250 mL flexible plastic container NDC 0264-7578-20	All presentations available.			Revised 10/17/2012
Hospira, Inc. Customer Service 1-877-946-7747	25%; 50 mL vial (NDC 0409-4031-01)	Next delivery mid May. Estimated recovery: 2Q 2013.	Please check with your wholesaler for all available inventory. Shortage per Manufacturer: Manufacturing delay	Other	Revised 5/3/2013
	20%; 250 mL container (NDC 0409-7715-02)	Available
	20%; 500 mL container (NDC 0409-7715-03)	Available
American Regent/Luitpold 1-800-645-1760	25%, 50 mL vial NDC 0517-4050-25	Unavailable	Shortage per Manufacturer: American Regent is currently not releasing Mannitol Injection.	Other	Reverified 5/7/2013
Baxter Customer Service: 1-800-ANA-DRUG (1-800-262-3784)	20% OSMITROL Injection (20% Mannitol Injection, USP). NDC: 0338-0357-02	Available	Shortage per Manufacturer: Product Available	Other	Reverified 5/7/2013
Baxter Customer Service: 1-800-ANA-DRUG (1-800-262-3784)	20% OSMITROL Injection (20% Mannitol Injection, USP). NDC: 0338-0357-03	Available	Shortage per Manufacturer: Product Available	Other	Reverified 5/7/2013

Mecasermin [rDNA origin] (Increlex) Injection (Initial posting – 4/26/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*
Ipsen Biopharmaceuticals Inc. Contact: 1-855-463-5127	INCRELEX (mecasermin [rDNA origin] injection), 10 mg/mL NDC-15054-1040-5	Ipsen Biopharmaceuticals Inc. has limited product available and cannot estimate a release date for a new batches.	Ipsen Biopharmaceuticals, Inc. (Ipsen) has been working with the Food and Drug Administration (FDA) in efforts to minimize any supply disruption. Current lots of Increlex in the marketplace were manufactured using an alternative drug substance manufacturing facility that has not been approved by the FDA. For more information on this release of supply, see Dear Healthcare Professional Letter (PDF - 49KB). For more information regarding the anticipated drug shortage for Increlex, see Dear Healthcare Professional Letter (PDF - 142KB). Contact Ipsen Biopharmaceuticals Inc. regarding product availability.	Relocation of the third party manufactur ing site. Shortage of the active ingredient

Methazolamide Tablets (Initial posting – 6/29/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Sandoz Customer Service: 1-609-627-8500	25 mg, 100s (NDC 0781-1072-01)	Available	N/A	Shortage of an active ingredient	Reverified 4/16/2013
	25 mg, 1000s (NDC 0781-1072-10)
	50 mg, 100s (NDC 0781-1071-01)
	50 mg, 1000s (NDC 0781-1071-10)
Fera Pharmaceuticals Customer Service 1-414-434-6604	25 mg, 100s (NDC 48102-0100-01)	Ample supply to meet the national market demand.	Shortage per Manufacturer: Available	Other	Reverified 1/18/2013
	50 mg, 100s (NDC 48102-0101-01)
	Neptazane- 25 mg, 90s (NDC 48102-0014-90)
	Neptazane- 50 mg, 90s (NDC 48102-0015-90)

Methoxsalen 1% topical lotion (Oxsoralen)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Valeant Pharmaceuticals International 1-866-819-9007			There is not yet an estimated release date. Shortage per Manufacturer: Manufacturing delays	Other	Reverified 7/6/2010

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Valeant Pharmaceuticals International
1-866-819-9007

There is not yet an estimated release date.

Shortage per Manufacturer:
Manufacturing delays

Other

Reverified 7/6/2010

Methyldopate Hydrochloride Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
American Regent, Inc./Luitpold: 1-800-645-1706	50 mg/mL, 5 mL vial, 10s (NDC 00517-8905-10)	Unavailable	Shortage per Manufacturer: American Regent is currently not releasing Methyldopate HCl Injection, USP.	Shortage of active ingredient	Reverified 5/7/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

American Regent, Inc./Luitpold:

1-800-645-1706

50 mg/mL, 5 mL vial, 10s (NDC 00517-8905-10)

Unavailable

Shortage per Manufacturer: American Regent is currently not releasing Methyldopate HCl Injection, USP.

Shortage of active ingredient

Reverified 5/7/2013

Methylphenidate Hydrochloride Tablets (Initial Posting Date – 2/19/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Mallinckrodt Customer Service: 1-800-325-8888	5 mg IR tablets (NDC 00406-1142-10)	Product temporairily unavailable.	Shortage per Manufacturer: Shortage of active ingredient.	Shortage of active ingredient	Reverified 4/19/2013
	10 mg IR tablets (NDC 00406-1144-01 and 00406-1144-10)
	20 mg IR tablets (NDC 00406-1146-01 and 00406-1146-10)

Methylphenidate Hydrochloride ER Tablets (Initial Posting Date – 2/19/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Mallinckrodt Customer Service: 1-800-325-8888	10 mg ER tablets (NDC 00406-1445-01)	Limited availability through Spring 2013.	Shortage per Manufacturer: Shortage of active ingredient.	Shortage of active ingredient	Reverified 4/19/2013
	20 mg ER tablets (NDC 00406-1473-01)	Limited availability through Spring 2013.
	20 mg ER tablets (NDC 00406-1473-01)	Product temporarily unavailable.

Methylin Chewable Tablets (Initial Posting Date – 2/19/2013)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Shionogi Pharma, Inc.: 1-800-461-3696	2.5 mg tablets (NDC 59630-760-10)	Product temporairily unavailable.	Shortage per Manufacturer: Manufacturing issues.	Other	Reverified 4/19/2013
	5 mg tablets (NDC 59630-761-10)
	10 mg tablets (NDC 59630-762-10)

Metoclopramide (Reglan) Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	5 mg/mL 2 mL vials (NDC 00409-3414-01)	Available	Please check with your wholesaler for available inventory. Shortage per manufacturer: Available	Other	Revised 5/3/2013
Teva Pharmaceuticals 1-800-545-8800	5 mg/mL, 2 mL vial, 25 count (NDC 00703-4502-04)	Teva has made the decision to re-introduce Metoclopramide to the market. We expect availability by Q3 2013.		Demand increase for the drug.	Reverified 4/15/2013

Company

Product

Availability and Estimated Shortage Duration

Related Information

Shortage Reason
(per New Legislation-FDASIA)*

Date Updated

Hospira Inc. Customer Service:
1-877-946-7747

5 mg/mL 2 mL vials (NDC 00409-3414-01)

Available

Please check with your wholesaler for available inventory.

Shortage per manufacturer: Available

Other

Revised 5/3/2013

Teva Pharmaceuticals
1-800-545-8800

5 mg/mL, 2 mL vial, 25 count (NDC 00703-4502-04)

Teva has made the decision to re-introduce Metoclopramide to the market. We expect availability by Q3 2013.

Demand increase for the drug.

Reverified 4/15/2013

Midazolam Hydrochloride (Versed) Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP 1-888-386-1300	1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12)	Available. Check wholesalers for inventory.	Check with wholesalers for inventory. Shortage per Manufacturer: Increased demand	Demand increase for the drug.	Revised 4/30/2013
	1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25)	Available. Check wholesalers for inventory.
	1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10)	Available. Check wholesalers for inventory.
	5 mg/mL, 5 mL vial, 10 count (NDC 63323-0412-05)	Available. Check wholesalers for inventory.
	5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10)	Backordered. Next release expected June 2013.
	5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02)	Available. Check wholesalers for inventory.
	5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25)	Available. Check wholesalers for inventory.
Bedford Customer Service: 1-800-562-4797	1 mg/mL, 2 mL preservative-free vial, 10 count (NDC 55390-0137-02)	Bedford has all midazolam presentations on back order and the company cannot estimate a release date.	The 1 mg/mL 2 mL and 10 mL vials and the 5 mg/mL 2 mL (1 mL fill), 5 mL and 10 mL vials are pending release while the other presentations will not be manufactured until capacity permits. Bedford Laboratories has temporarily suspended the distribution of Ben Venue Laboratories manufactured products. Availability of products is updated on the Bedford Laboratories website Shortage per Manufacturer: Temporary suspension of manufacturing.	Discontinuation of the manufacture of the drug.

	1 mg/mL, 5 mL preservative-free vial, 10 count (NDC 55390-0137-05)
	1 mg/mL, 10 mL vial, 10 count (NDC 55390-0125-10)
	5 mg/mL, 2 mL preservative-free vial, 10 count (NDC 55390-0138-02)
	5 mg/mL, 1 mL preservative-free, in 2 mL vial, 10 count (NDC 55390-0138-01)
	5 mg/mL, 5 mL vial, 10 count (NDC 55390-0126-05)
	5 mg/mL, 10 mL vial, 10 count (NDC 55390-0126-10)5 mg/mL, 10 mL vial, 10 count (NDC 55390-0126-10)
Hospira, Inc. Customer Service: 1-877-946-7747	1 mg/mL, 2 mL preservative-free Luer-lock syringe (NDC 0409-2306-62)	Available	Hospira discontinued the following products: 1 mg/mL, 2 mL iSecure syringe (NDC 0409-2306-22) 5 mg/mL, 1 mL preservative-free iSecure syringe (NDC 0409-2307-21). Shortage per Manufacturer: Available/Other manufacturer/withdrawal	Demand increase for the drug/Other	Revised 5/3/2013
	1 mg/mL, 2 mL preservative-free vial (NDC 0409-2305-17)	Next delivery May. Estimated recovery 3Q 2013
	1 mg/mL, 5 mL preservative-free vial (NDC 0409-2305-05)	Next delivery April. Estimated recovery 2Q 2013
	1 mg/mL, 2 mL preservative-free iSecure syringe (NDC 0409-2306-12)	Available
	1 mg/mL, 10 mL vial (NDC 0409-2587-05)	Available
	1 mg/ml, 10 mL vial (NDC 0409-2587-05)	Next delivery April Estimated recovery 2Q 2013
	5 mg/mL, 1 mL preservative-free vial (NDC 0409-2308-01)	Available
	5 mg/mL, 5 mL vial (NDC 0409-2596-03)	Next delivery April Estimated recovery 2Q 2013
	5 mg/mL, 10 mL vial (NDC 0409-2596-05)	Next delivery April Estimated recovery 2Q 2013
	5 mg/mL, 1 mL preservative-free Luer-Lock syringe (NDC 0409-2307-60)	Next delivery late April Estimated recovery 2Q 2013
	5 mg/mL, 2 mL preservative-free vial (NDC 0409-2308-02)	Available
Sun Pharma USA (Caraco Pharmaceutical Laboratories, Ltd.) Customer Service: 1-800-818-4555	2mg/2mL (1mg/mL) NDC: 57664-0633-43, 10 pack	Readily Available	Product Available	Demand increase for the drug.	Posted 9/14/2012
	25mg/5mL (5mg/mL) NDC: 57664-0634-44, 10 pack
	50mg/10mL (5mg/mL) NDC: 57664-0634-45, 10 pack
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	2 mL vial, 1 mg/mL (NDC 0641-6057-25)25 pack (NDC 0641-6057-10)10 pack	West-Ward currently has limited quantities available. There is a backorder situation on the 1 mg/mL, 2 mL vail (25 pack). West-Ward has accelerated production on all Midazolam product codes.	West-Ward is anticipating having additional lots of inventory available by the end of March 2013. Product will be made available as it is released.	Demand increase for the drug.	Revised 2/11/2013
	5 mL vial, 1 mg/mL (NDC 0641-6059-10)
	10 mL vial, 1 mg/mL (NDC 0641-6056-10)
	1 mL vial, 5 mg/mL (NDC 0641-6061-25)25 pack(NDC 0641-6061-10)10 pack
	2 mL vial, 5 mg/mL (NDC 0641-6063-25)25 pack (NDC 0641-6063-10)10 pack
	10 mL vial, 5 mg/mL (NDC 0641-6060-10)
Akorn: 1-800-932-5676	1 mg / mL; (2 mL x 10 pack) (NDC 17478-0523-02)	Readily available	NA	NA	Reverified 4/3/2013
	1 mg / mL; (5 mL x 25 pack) (NDC 17478-0523-55)	Readily available
	1 mg / mL; (10 mL x 10 pack) (NDC 17478-0523-10)	Readily available
	5 mg / mL; (1 mL x 10 pack) (NDC 17478-0524-01)
	5 mg / mL; (2 mL x 10 pack) (NDC 17478-0524-02)
	5 mg / mL; (5 mL x 10 pack) (NDC 17478-0524-05)
	5 mg / mL; (10 mL x 10 pack) (NDC 17478-0524-10)
Sagent Pharmaceuticals, Inc. 1-866-625-1618	2 mg/2 mL vial (preservative-free), NDC 25021-655-02	Available	Shortage per Manufacturer: Product Available	Demand increase for the drug.	Reverified 5/13/2013
	5 mg/5 mL vial, (preservative-free) NDC 25021-655-05	Allocation
	5 mg/mL vial, (preservative-free) NDC 25021-656-01	Allocation
	10 mg/2 mL vial, (preservative-free) NDC 25021-656-02	Available
	10 mg/10 mL vial, NDC 25021-660-10	On allocation
	25 mg/5 mL vial, NDC 25021-661-05	On allocation
	50 mg/10 mL vial, NDC 25021-661-10	Available

Morphine Sulfate Injection

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	1 mg/mL, 30 mL PCA vial (NDC 0409-2029-02)	Next delivery late May. Estimated recovery: 2Q 2013	Please check with your wholesaler for available inventory. Shortage per Manufacturer: Manufacturing delay/Available	Other	Revised 5/3/2013
	5 mg/mL; 30 mL PCA vial (NDC 0409-6028-04)	Available
	50 mg/mL, 20 mL vial (NDC 0409-1134-03)	Next delivery June Estimated recovery: 2Q 2013
	50 mg/mL, 50 mL vial (NDC 0409-1134-05)	Available
	25 mg/mL; 4 mL Add-vantage vial (NDC 0409-6177-14)	Next delivery late May Estimated recovery: 2Q 2013
	25 mg/mL, 10 mL Add-Vantage vial (NDC 0409-6179-14)	Next delivery June Estimated recovery: 2Q 2013
Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136	1mg/mL, 30mL PCA Vial (NDC 0548-1911-25)	Amphastar will regularly release products.	Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues.	Demand increase for the drug.	Reverifed 5/13/2013







West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	1 mL vial, 5 mg/mL (NDC 0641-6073-25)	Available in limited quantities	West-Ward has accelerated production on all Morphine codes and is projecting to have additional inventory available for release in the February-March 2013 timeframe. Product will be made available as it is released	Demand increase for the drug.	Revised 2/11/2013
	1 mL vial, 8 mg/mL (NDC 0641-6075-25)	Backordered
	1 mL vial, 10 mg/mL) (NDC 0641-6070-25)	Backordered
	10mL vial, 10 mg/mL (NDC 0641-6068-01)	Backordered
	1 mL vial, 15 mg/mL (NDC 0641-6071-25)	Backordered
	20 mL vial, 15 mg/mL (NDC 0641-6072-01)	Backordered

Morphine Sulfate (Astramorph PF, Duramorph, Infumorph) Injection (Preservative Free)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP 1-888-386-1300 Astramorph (preservative-free) Inj	0.5 mg/mL 2 mL ampule, 10 count (NDC 63323-0291-80)	APP has preservative-free Astramorph 0.5 mg/mL 2 mL ampules, 1 mg/mL 2 mL ampules and 10 mL ampules, and 0.5 mg/mL 10 mL vials on back order with an estimated release timing TBD.	Shortage per Manufacturer: Manufacturing delay	Other	Reverified 4/30/2013
	0.5 mg/mL 10 mL vial, 5 count (NDC 63323-0291-10)
	1 mg/mL 2 mL ampule, 10 count (NDC 63323-0292-80)
	1 mg/mL, 10 mL vial (NDC 63323-0292-10)
Hospira, Inc. Customer Service: 1-877-946-7747	0.5 mg/mL; 10 mL vial (NDC 0409-3814-12)	Next delivery late June. Estimated recovery 2Q 2013	Shortage per manufacturer: Manufacturing delay.	Other	Revised 5/3/2013
	1 mg/mL; 10 mL vial (NDC 0409-3815-12)	Next delivery early June. Estimated recovery 2Q 2013
	25 mg/mL; 1 mL vial (NDC 0409-1135-02)	Next delivery June Estimated recovery 2Q 2013
	2mg/mL; 1mL Carpuject (NDC0409-1890-01	Available	New preservative-free product to replace preserved product NDC 0409-1762-30
	4mg/mL; 1mL Carpuject (NDC 0409-1891-01)	Available	New preservative-free product to replace preserved product NDC 0409-1258-30
	8mg/mL; 1mL Carpuject (NDC 0409-1892-01)	Available	New preservative-free product to replace preserved product NDC 0409-1260-69
	10mg/mL; 1mL Carpuject (NDC 0409-1893-01)	Available	New preservative-free product to replace preserved product NDC 0409-1261-30
	15mg/mL; 1mL Carpuject (NDC 0409-1894-01)	Available	New preservative-free product to replace preserved product NDC 0409-1264-31
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	Infumorph 20 mL ampul, 10 mg/mL (NDC 0641-6039-01)	West-Ward is currently experiencing a backorder situation on all presentations. West-Ward has accelerated production on this product.	West-Ward is anticipating having product available by the end of March 2013. Product will be made available as it is released.	Demand increase for the drug.	Revised 2/11/2013
	Infumorph 20 mL ampul, 25 mg/mL (NDC 0641-6040-01)
	Duramorph 10 mL ampul, 1 mg/mL) (NDC 0641-6019-10)
	Duramorph 10mL ampul, 0.5 mg/mL (NDC 0641-6020-10)

Multi-Vitamin Infusion (Adult and pediatric)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira , Inc. Customer Service 1-877-946-7747	MVI-12 Adult; 10 mL vial (NDC 61703-423-81)	Adult formulations: temporarily suspended production.	Shortage per Manufacturer: Adult formulations temporarily suspended production. Shortage per Manufacturer: Pediatric formulation-manufacturing issue.	Discontinuation of the manufacture of the drug.	Reverified 4/29/2013
	MVI-12 Adult; 2x50 mL PBP(NDC 61703-423-83)
	MVI Adult; 10 mL vial (NDC 61703-422-81)
	MVI Adult; 2x5 mL (NDC 61703-422-82)
	MVI Adult 2x50 mL PBP (NDC 61703-422-83)
	MVI Pediatric; 5 mL vial (NDC 61703-421-53)	Available
Baxter (Infuvite adult and pediatric IV solution) Customer Service: 1-888-229-0001	INFUVITE Pediatric, Multiple Vitamins for Injection. Single Dose package. (NDC 54643-5646-1)	Baxter is the distributor of INFUVITE Multi Vitamins. Baxter has these multi-vitamin products on allocation and is working with the manufacturer to maximize the availability of INFUVITE Multi Vitamins. Allocated availability through Sept. 2013.	For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition	Requirements related to complying with good manufacturing practices.	Reverified 5/7/2013
	INFUVITE Adult, Multiple Vitamins for Injection. Single dose package. (NDC 54643-5649-1)
	INFUVITE Adult, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5649-2)
	INFUVITE Pediatric, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5647-0)

Nalbuphine HCl (Nubain) Injection (Initial Posting - 5/15/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	10 mg/mL; 1 mL ampule (NDC 0409-1463-01)	Next delivery July Estimated recovery 3Q 2013	Please check with your wholesaler for available inventory. Shortage per Manufacturer: Manufacturing delay/Available	Other	Revised 5/3/2013
	10 mg/mL; 10 mL vial (NDC 0409-1464-01)	Next delivery May Estimated recovery 2Q 2013
	20 mg/mL; 1 mL ampule (NDC 0409-1465-01)	Next delivery July Estimated recovery 3Q 2013
	20 mg/mL; 10 mL vial (NDC 0409-1467-01)	Next delivery May Estimated recovery 2Q 2013

Naloxone (Narcan) Injection (Initial Posting Date) - 2/22/2012

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Hospira Inc. Customer Service: 1-877-946-7747	Naloxone 0.4 mg/mL Injection; 1mL vial (NDC 00409-1215-01)	Available	Please check with your wholesaler for available inventory. Shortage per Manufacturer manufacturing delay/Available	Other	Revised 5/3/2013
	Naloxone 0.4 mg/mL Injection; 10mL MDV (NDC 00409-1219-01)	Next delivery May. Estimated recovery 2Q 2013
	Naloxone 0.4 mg/mL Injection; 1mL in 2mL Carpuject (NDC 00409-1782-69)	Available
Amphastar Pharmaceuticals, Inc. 1-800-423-4136	1mg/mL, 2mL Prefilled Syringe with needles (NDC 76329-1469-5)	Available		N/A	Reverified 5/13/2013
Amphastar Pharmaceuticals, Inc. 1-800-423-4136	1mg/mL, 2mL Prefilled Syringe without needles (NDC 76329-3369-1)	Available		N/A	Reverified 5/13/2013

Neostigmine Methylsulfate Injection, USP (Initial Posting - 1/14/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
APP Customer Service 1-888-386-1300	0.5 mg/mL, 5 mg/10 mL MDV (NDC # 63323-382-10)	Backordered. Next release anticipated May 2013. Check wholesaler for inventory.		Increase in demand.	Reverified 4/30/2013
	1 mg/mL, 10 mg/10 mL MDV (NDC # 63323-383-10)	Back-ordered. Check wholesaler inventory. Next release anticipated May 2013


American Regent/Luitpold 1-800-645-1706	1 mg/mL, 10 mL vial, package of 25 (NDC 00517-0033-25)	Available	American Regent is currently releasing Neostigmine Methylsulfate Injection 1 mg/mL	Other	Reverified 5/7/2013
	1 mg/mL, 10 mL vial, package of 25 (NDC 00517-0033-25)	Available
	0.5 mg/mL, 10 mL vial, package of 25 (NDC 00517-0034-25)	Unavailable	American Regent is currently not releasing Neostigmine Methylsulfate Injection 0.5 mg/mL
	0.5 mg/mL, 10 mL vial, package of 25 (NDC 00517-0034-25)	Unavailable
West-Ward Pharmaceuticals Customer Service: 1-800-631-2174	Neostigmine Methylsulfate Injection, USP 0.5 mg/mL, 10 mL vial (NDC 0641-6076-10) 1 mg/mL, 10 mL vial (NDC 0641-6077-10)	West-Ward currently has limited quantities available of both presentations West-Ward has accelerated production on this product.	West-Ward is anticipating having product available by the end of February 2013. Product will be made available as it is released.	Demand increase for the drug.	Revised 2/11/2013

Nitroglycerin Ointment USP, 2% (Nitro-Bid) (Initial posting - 10/23/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Savage Laboratories, A division of Fougera Pharmaceuticals Inc. 1-800-645-9833	Nitro-Bid (Nitroglycerin Ointment USP, 2%); 1 g foilpac (NDC 0281-0326-08)	Backorder	Shortage per manufacturer: Manufacturing delays	Other	Revised 5/15/2013
	Nitro-Bid (Nitroglycerin Ointment USP, 2%); 30 g tube (NDC 0281-0326-30)	Product now available; next release early June		Demand increase for the drug
	Nitro-Bid (Nitroglycerin Ointment USP, 2%); 60 g tube (NDC 0281-0326-60)	Product now available		Demand increase for the drug

Norethindrone and Ethinyl Estradiol Tablets, USP (Ovcon 50 Tablets) (Initial Posting -4/6/2012)

Company	Product	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per New Legislation-FDASIA)*	Date Updated
Warner Chilcott Customer Service 1-877-597-9462	28x6 (NDC 0430-0585-14)	No estimated date of availability.	Shortage per Manufacturer: Manufacturing delays	Other
Warner Chilcott Customer Service 1-877-597-9462	28x3 (NDC 0430-0585-45)	No estimated date of availability.	Shortage per Manufacturer: Manufacturing delays	Other

Current Drug Shortages Index

Drugs

Section Contents Menu

Drug Safety and Availability

Resources for You

Current Drug Shortages L - N

Links on this page: